Verition Fund Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
184,445
+12,422
| +7% | +$113K | 0.01% | 1541 |
|
|
2025
Q1 | $1.37M | Buy |
172,023
+3,008
| +2% | +$23.9K | 0.01% | 1426 |
|
|
2024
Q4 | $918K | Buy |
169,015
+32,593
| +24% | +$177K | ﹤0.01% | 1583 |
|
|
2024
Q3 | $985K | Sell |
136,422
-1,180
| -0.9% | -$8.52K | 0.01% | 1334 |
|
|
2024
Q2 | $1.49M | Sell |
137,602
-2,847
| -2% | -$30.9K | 0.01% | 992 |
|
|
2024
Q1 | $2.63M | Buy |
140,449
+7,949
| +6% | +$149K | 0.02% | 757 |
|
|
2023
Q4 | $2.87M | Sell |
132,500
-12,800
| -9% | -$277K | 0.02% | 574 |
|
|
2023
Q3 | $2.99M | Buy |
145,300
+6,195
| +4% | +$127K | 0.03% | 566 |
|
|
2023
Q2 | $6.54M | Buy |
139,105
+2,008
| +1% | +$94.4K | 0.09% | 271 |
|
|
2023
Q1 | $5.75M | Buy |
137,097
+2,431
| +2% | +$102K | 0.08% | 287 |
|
|
2022
Q4 | $5.14M | Sell |
134,666
-2,191
| -2% | -$83.6K | 0.08% | 258 |
|
|
2022
Q3 | $5.36M | Sell |
136,857
-3,345
| -2% | -$131K | 0.06% | 336 |
|
|
2022
Q2 | $4.53M | Buy |
+140,202
| New | +$4.53M | 0.09% | 282 |
|
|
2021
Q3 | – | Sell |
-11,146
| Closed | -$633K | – | 1990 |
|
|
2021
Q2 | $633K | Buy |
+11,146
| New | +$633K | 0.01% | 869 |
|
|
2020
Q1 | – | Sell |
-59,047
| Closed | -$4.26M | – | 878 |
|
|
2019
Q4 | $4.26M | Buy |
+59,047
| New | +$4.26M | 0.08% | 117 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1165 |
|
|
2019
Q2 | – | Sell |
-1,830
| Closed | -$291K | – | 1211 |
|
|
2019
Q1 | $291K | Buy |
+1,830
| New | +$291K | 0.01% | 780 |
|
|
2018
Q4 | – | Sell |
-1,963
| Closed | -$277K | – | 1110 |
|
|
2018
Q3 | $277K | Buy |
+1,963
| New | +$277K | 0.01% | 987 |
|
|
2018
Q2 | – | Sell |
-1,606
| Closed | -$259K | – | 1201 |
|
|
2018
Q1 | $259K | Buy |
+1,606
| New | +$259K | 0.02% | 839 |
|